Total Subjects
197,050
Age Range
48 (18-92)
Male
72,141
Female
124,909
Lipid Profile
196,883
Glucose Data
196,887
Liver Enzymes
196,882
Kidney Markers
196,883
Age Distribution by Gender
Gender Distribution Across Age Groups
Cardiovascular Biomarkers Correlation Matrix
Lipid Profile Distribution
Glucose & Liver Enzymes
Kidney Function Markers
Biomarker Summary Statistics
| Characteristic | N | Overall N = 197,0501 |
Female N = 124,9091 |
Male N = 72,1411 |
|---|---|---|---|---|
| Age | 197,050 | |||
| < 30 | 12,201 (6.2%) | 7,543 (6.0%) | 4,658 (6.5%) | |
| ≥ 70 | 3,863 (2.0%) | 2,212 (1.8%) | 1,651 (2.3%) | |
| 30-39 | 45,222 (22.9%) | 27,659 (22.1%) | 17,563 (24.3%) | |
| 40-49 | 45,415 (23.0%) | 28,807 (23.1%) | 16,608 (23.0%) | |
| 50-59 | 50,608 (25.7%) | 34,250 (27.4%) | 16,358 (22.7%) | |
| 60-69 | 39,741 (20.2%) | 24,438 (19.6%) | 15,303 (21.2%) | |
| Total Cholesterol (mg/dL) | 196,883 | |||
| Mean (SD) | 195.5 (37.0) | 197.7 (36.3) | 191.7 (37.9) | |
| Median (Q1, Q3) | 193.0 (171.0, 217.0) | 195.0 (172.0, 220.0) | 190.0 (167.0, 213.0) | |
| Triglycerides (mg/dL) | 196,882 | |||
| Mean (SD) | 113.6 (95.1) | 100.8 (73.0) | 135.6 (121.4) | |
| Median (Q1, Q3) | 91.0 (63.0, 135.0) | 82.0 (59.0, 120.0) | 108.0 (74.0, 160.0) | |
| HDL Cholesterol (mg/dL) | 196,883 | |||
| Mean (SD) | 55.5 (13.8) | 59.4 (13.6) | 48.8 (11.4) | |
| Median (Q1, Q3) | 54.0 (45.0, 64.0) | 58.0 (50.0, 68.0) | 47.0 (41.0, 55.0) | |
| LDL Cholesterol (mg/dL) | 196,883 | |||
| Mean (SD) | 119.8 (32.1) | 119.2 (32.0) | 120.8 (32.1) | |
| Median (Q1, Q3) | 118.0 (97.0, 140.0) | 117.0 (97.0, 139.0) | 120.0 (99.0, 141.0) | |
| Fasting Glucose (mg/dL) | 196,884 | |||
| Mean (SD) | 95.7 (20.2) | 93.8 (18.4) | 98.9 (22.5) | |
| Median (Q1, Q3) | 92.0 (87.0, 98.0) | 90.0 (86.0, 96.0) | 94.0 (89.0, 100.0) | |
| HbA1c (%) | 196,802 | |||
| Mean (SD) | 5.7 (0.8) | 5.7 (0.7) | 5.8 (0.9) | |
| Median (Q1, Q3) | 5.6 (5.4, 5.9) | 5.6 (5.4, 5.8) | 5.6 (5.4, 5.9) | |
| SGOT/AST (U/L) | 196,882 | |||
| Mean (SD) | 23.3 (12.6) | 22.2 (11.6) | 25.3 (14.1) | |
| Median (Q1, Q3) | 21.0 (18.0, 26.0) | 21.0 (17.0, 25.0) | 23.0 (19.0, 28.0) | |
| SGPT/ALT (U/L) | 196,511 | |||
| Mean (SD) | 24.0 (21.2) | 20.5 (18.4) | 30.1 (24.1) | |
| Median (Q1, Q3) | 19.0 (14.0, 27.0) | 16.0 (12.0, 23.0) | 24.0 (17.0, 35.0) | |
| BUN (mg/dL) | 196,882 | |||
| Mean (SD) | 13.1 (4.0) | 12.6 (3.8) | 14.1 (4.2) | |
| Median (Q1, Q3) | 12.7 (10.5, 15.1) | 12.1 (10.1, 14.5) | 13.6 (11.5, 16.0) | |
| Creatinine (mg/dL) | 196,881 | |||
| Mean (SD) | 0.7 (0.4) | 0.6 (0.2) | 0.9 (0.5) | |
| Median (Q1, Q3) | 0.7 (0.6, 0.8) | 0.6 (0.5, 0.7) | 0.9 (0.8, 1.0) | |
| Uric Acid (mg/dL) | 196,880 | |||
| Mean (SD) | 5.4 (1.4) | 4.8 (1.1) | 6.4 (1.4) | |
| Median (Q1, Q3) | 5.2 (4.4, 6.3) | 4.7 (4.1, 5.5) | 6.3 (5.5, 7.2) | |
| 1 n (%) | ||||